AlphaClone International ETF EBIT

The latest EBIT for ALFI is $-1.4B as of March 2026. That compares with $-1.6B in the prior-year period — up 12.1% year over year. That is below the sector sector average of $-69M. Investors often review this figure alongside AlphaClone International ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, ALFI's EBIT moved from $-1.6B to $-1.4B — a 12.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AlphaClone International ETF's operating scale or balance-sheet position.

Against its sector companies, ALFI currently prints $-1.4B for EBIT, while the sector average sits near $-69M. That is roughly 1920.8% below the sector mean. Large gaps often invite a closer look at AlphaClone International ETF's growth, margins, and balance sheet.

A EBIT figure of $-1.4B for ALFI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-69M. Explore the charts below for those layers of context.

After noting ALFI's EBIT ($-1.4B), review year-over-year change from $-1.6B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.